Eli Lilly (LLY) Stock Up Almost 50% Year to Date: Here's Why By: TalkMarkets August 17, 2023 at 15:09 PM EDT Eli Lilly and Company (LLY) boasts a solid portfolio of core drugs in diabetes, autoimmune diseases and cancer. Read More >> Related Stocks: Amphastar Pharmaceuticals, Inc. - Common Stock Eli Lilly
